In addition, a recent study [22] showed that inhibition of CXCR1/2 by reparixin reduced NET formation, multiorgan injury, and mortality in septic mice without impairing bacterial clearance, which highlights that CXCR1/2 signalling-induced NET formation is a therapeutic target in sepsis. Here, CXCR1 is linked to Sepsis.